Physician profile
Devin William Collins
NPI 1417477852
$34,594.73
in general payments reported to CMS, 2019-2025
31 companies · $2,199 in 2025
The $2,199 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.82 · 2020: $65.53 · 2021: $307 · 2022: $4,648 · 2023: $4,929 · 2024: $22K · 2025: $2,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $5,328 · Travel and Lodging: $4,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,679.00 |
| Food and Beverage | $5,327.69 |
| Travel and Lodging | $4,473.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $18,934.49 | 2022-2024 | Xiaflex |
| Acumed LLC | $7,544.77 | 2021-2025 | Acumed, Acumed, Inframe Implant |
| Mvp Orthopedics INC | $1,497.00 | 2022-2023 | |
| Cgg Medical INC | $1,237.04 | 2021-2022 | |
| Coastal Medical Technologies LLC | $915.77 | 2023-2025 | |
| Arthrex, INC. | $777.10 | 2023 | Distal Extremities Implants Soft Tissue H&W Mini Tightropes |
| Stryker Corporation | $645.41 | 2020-2025 | Gamma, Insignia, Triathlon |
| Axogen | $543.63 | 2022-2025 | Avance Nerve Graft |
| Skeletal Dynamics INC | $371.14 | 2023-2024 | Ijs, Geminus, Implate |
| Depuy Synthes Sales INC. | $341.39 | 2022-2023 | Na, Va-Lcp, Healix Knotless Peek |
| Medartis INC. | $300.94 | 2023-2024 | Aptus |
| Alafair Biosciences, INC. | $238.41 | 2024 | Versawrap |
| Zimmer Biomet Holdings, INC. | $234.60 | 2021-2024 | Dvr Anatomic Kickstand, Tapestry, A.L.P.S. |
| Orthofix Medical, INC. | $187.73 | 2023-2025 | Physio-Stim, Cervical-Stim |
| Polynovo North America LLC | $162.83 | 2024 | Novosorb Btm |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exsomed Corporation | $96.00 | 2022 | |
| Smith+Nephew, INC. | $89.68 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Avita Medical Americas, LLC | $72.72 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $68.50 | 2019 | |
| Integra Lifesciences Corporation | $52.63 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $46.34 | 2020-2021 | |
| Ossdsign USA Incorporated | $45.85 | 2023 | |
| Bioventus LLC | $31.00 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Biocircuit Technologies INC | $27.23 | 2025 | Nerve Tape |
| Avanos Medical | $25.32 | 2019 | |
| Kci USA, INC. | $21.31 | 2021 | |
| Checkpoint Surgical, INC | $20.66 | 2023 | Checkpoint Stimulators |
| Osteomed LLC | $17.50 | 2022 | |
| Endo USA, INC. | $16.57 | 2024 | Xiaflex |
| Heraeus Medical, LLC. | $16.49 | 2024 | |
| Painteq LLC | $14.68 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.